Handong Jiang
Impact in
-
- Drug Transport and Resistance Mechanisms
- Cancer Immunotherapy and Biomarkers
- Cytokine Signaling Pathways and Interactions
-
- Cancer, Lipids, and Metabolism
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Medical Imaging and Pathology Studies 3
- Lung Cancer Treatments and Mutations 3
- Oncology 8
- Drug Transport and Resistance Mechanisms 4
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Shan Xue (12 shared papers)Wenjie You (6 shared papers)Hui Qin (5 shared papers)Xueqing Liu (5 shared papers)Bi Chen (5 shared papers)Huashi Guan (1 shared paper)Jieming Qu (1 shared paper)Zili Wang (1 shared paper)
- Journals
- Scientific Reports (2 papers)Acta Pharmacologica Sinica (2 papers)Lung Cancer (2 papers)Acta Pharmaceutica Sinica B (1 paper)Oncology Reports (1 paper)
- Partner nations
- ChinaGermanyUnited Kingdom
In The Last Decade
Handong Jiang
22 papers receiving 403 citations
Peers
Comparison fields: 5 of 80
- Oncology 158
- Cancer Research 57
- Pulmonary and Respiratory Medicine 96
- Immunology 52
- Molecular Biology 164
Countries citing papers authored by Handong Jiang
This map shows the geographic impact of Handong Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Handong Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Handong Jiang more than expected).
Fields of papers citing papers by Handong Jiang
This network shows the impact of papers produced by Handong Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Handong Jiang. The network helps show where Handong Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Handong Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 50 | |
| 2 | 2021 | 46 | |
| 3 | 2016 | 41 | |
| 4 | 2017 | 36 | |
| 5 | 2016 | 34 | |
| 6 | 2021 | 33 | |
| 7 | 2019 | 29 | |
| 8 | 2020 | 22 | |
| 9 | 2009 | 20 | |
| 10 | Prevention of Pulmonary Fibrosis via Trichostatin A (TSA) in Bleomycin Induced Rats. | 2014 | 19 |
| 11 | 2016 | 18 | |
| 12 | 2014 | 14 | |
| 13 | 2009 | 13 | |
| 14 | 2019 | 9 | |
| 15 | 2023 | 8 | |
| 16 | [Therapeutic effect and mechanism of sulfate polysaccharide of algae on lung cancer]. | 2004 | 4 |
| 17 | 2022 | 4 | |
| 18 | 2024 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2019 | 1 |
About Handong Jiang
Handong Jiang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Infectious Diseases, having authored 24 papers that have together received 407 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Drug Transport and Resistance Mechanisms (4 papers), Medical Imaging and Pathology Studies (3 papers), Cancer, Lipids, and Metabolism (3 papers), COVID-19 Clinical Research Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Long-Term Effects of COVID-19 (2 papers). The work is most often cited by research in Oncology (158 citations), Cancer Research (57 citations), Pulmonary and Respiratory Medicine (96 citations), Immunology (52 citations) and Molecular Biology (164 citations). Handong Jiang has collaborated with scholars based in China, Germany and United Kingdom. Frequent co-authors include Shan Xue, Wenjie You, Hui Qin, Xueqing Liu, Bi Chen, Huashi Guan, Jieming Qu, Zili Wang, Bi Chen and Bin Liu. Their work appears in journals such as Scientific Reports, Acta Pharmacologica Sinica, Lung Cancer, Acta Pharmaceutica Sinica B and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.